Skip to content

28th Annual TNP Conference Session S32 Evaluation -Atrial Fibrillation: Applying Latest Evidence to Treatment

28th Annual TNP Conference Session S32-Atrial Fibrillation: Applying Latest Evidence to Treatment

Speaker: Louisa Chika Ikpeama 
Saturday, September 10, 2016

The objectives for this session were: 
By the end of this session, attendants will be able to
1. Describe the mechanism of atrial fibrillation.
2. Identify reversible risk factors to atrial fibrillation
3. Explain important key factors to choosing rhythm vs rate control
4. Discuss anti-arrhythmic medications used for treatment of atrial fibrillation
5. Discuss anticoagulation therapy: warfarin vs novel anticoagulants
6. Evaluate indications for ablation therapy. 

All of the identified objectives were met satisfactorily.(Required.)
The speaker was prepared and knowledgeable about the topic.(Required.)
The speaker was organized and effective.(Required.)
The teaching / learning strategies were effective for the content presented.(Required.)
The content was relevant to my nursing practice.(Required.)
The classroom facility was conducive to my learning.(Required.)
The content of the program was balanced and free of commercial bias.(Required.)
I would recommend offering this program again at a future conference.
Strongly Disagree
Disagree
No Opinion
Agree
Strongly Agree
I would recommend this speaker for future conference.
Strongly Disagree
Disagree
No Opinion
Agree
Strongly Agree